Back
Arcus Biosciences Quote, Financials, Valuation and Earnings
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
51
RCUS
Arcus Biosciences
Last Price:
16.48
Seasonality Move:
7.99%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcus Biosciences Price Quote
$16.48
-0.25 (-1.49%)
(Updated: September 18, 2024 at 6:55 PM ET)
Arcus Biosciences Key Stats
Buy
51
Arcus Biosciences (RCUS)
is a Buy
Day range:
$16.60 - $17.31
52-week range:
$12.95 - $20.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.54
P/B ratio:
2.41%
Volume:
394.7K
Avg. volume:
586.3K
1-year change:
-18.67%
Market cap:
$1.5B
Revenue:
$117M
EPS:
$-3.09
How Much Does Arcus Biosciences Make?
-
How Much Are Arcus Biosciences's Sales Annually?
RCUS Revenues are $117M -
How Much Profit Does Arcus Biosciences's Make A Year?
RCUS net income is -$307M
Is Arcus Biosciences Growing As A Company?
-
What Is Arcus Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcus Biosciences Stock Price Performance
-
Did Arcus Biosciences Stock Go Up Last Month?
Arcus Biosciences share price went up by 7.24% last month -
Did RCUS's Share Price Rise Over The Last Year?
RCUS share price fell by -18.67% over the past 1 year
What Is Arcus Biosciences 52-Week High & Low?
-
What Is Arcus Biosciences’s 52-Week High Share Price?
Arcus Biosciences has traded as high as $20.60 over the past 52 weeks -
What Is Arcus Biosciences’s 52-Week Low Share Price?
Arcus Biosciences has traded as low as $12.95 over the past 52 weeks
Arcus Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcus Biosciences?
-
How Much Debt Does Arcus Biosciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arcus Biosciences Have?
Cash and short term investments quarterly total is $969M -
What Is Arcus Biosciences’s Book Value Per Share?
Book value per share is 6.96
Is Arcus Biosciences Cash Flow Positive?
-
What Is RCUS Cash Flow From Operations?
Cash flow from operations (TTM) is -$247M -
What Is Arcus Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $240M -
What Is Arcus Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$67M
Arcus Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
RCUS return on invested capital is -43.08% -
What Is Arcus Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -20.8% -
What Is RCUS Return On Equity?
ROE is a measure of profitability and is -43.08%
Arcus Biosciences Earnings Date & Stock Price
-
What Is Arcus Biosciences's Stock Price Today?
A single share of RCUS can be purchased today for 16.73 -
What Is Arcus Biosciences’s Stock Symbol?
Arcus Biosciences trades on the nyse under the ticker symbol: RCUS -
When Is Arcus Biosciences’s Next Earnings Date?
The next quarterly earnings date for Arcus Biosciences is scheduled on November 7, 2024 -
When Is RCUS's next ex-dividend date?
Arcus Biosciences's next ex-dividend date is September 19, 2024 -
How To Buy Arcus Biosciences Stock?
You can buy Arcus Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcus Biosciences Competitors
-
Who Are Arcus Biosciences's Competitors?
Below is a list of companies who compete with Arcus Biosciences or are related in some way:
Arcus Biosciences Dividend Yield
-
What Is RCUS Dividend Yield?
Arcus Biosciences’s dividend yield currently is 0% -
What Is Arcus Biosciences’s Payout Ratio?
Arcus Biosciences’s payout ratio is 0% -
When Did Arcus Biosciences Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Arcus Biosciences’s Dividend Per Share?
Arcus Biosciences pays a dividend of $0.00 per share
Arcus Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 26.38% |
| Revenue: | 34.48% | 47.24% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 33.13 |
| Upside from Last Price: | 98% |